|
ZNF146 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.39690000000581E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.021600E-04 |
| Normal-vs-Stage2 |
1.430690E-04 |
| Normal-vs-Stage3 |
1.83549999999144E-06 |
| Normal-vs-Stage4 |
1.51589999997093E-07 |
| Stage1-vs-Stage2 |
5.465000E-01 |
| Stage1-vs-Stage3 |
1.645810E-01 |
| Stage1-vs-Stage4 |
2.735700E-02 |
| Stage2-vs-Stage3 |
6.812000E-01 |
| Stage2-vs-Stage4 |
2.757800E-01 |
| Stage3-vs-Stage4 |
4.255000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.7790000000083E-06 |
| Normal-vs-AfricanAmerican |
3.112300E-02 |
| Normal-vs-Asian |
3.200800E-04 |
| Caucasian-vs-AfricanAmerican |
3.756600E-01 |
| Caucasian-vs-Asian |
9.268600E-01 |
| AfricanAmerican-vs-Asian |
4.641800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.86593000000013E-05 |
| Normal-vs-Female |
2.71699999998543E-06 |
| Male-vs-Female |
9.101600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.197800E-04 |
| Normal-vs-Age(41-60Yrs) |
7.52129999948004E-07 |
| Normal-vs-Age(61-80Yrs) |
1.07380000002877E-06 |
| Normal-vs-Age(81-100Yrs) |
8.517800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.333590E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.739550E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.790000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.278800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.023800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.579000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.046400E-01 |
| Classical-VS-Follicular |
8.440200E-03 |
| Classical-VS-Other |
4.092000E-01 |
| Classical-VS-Normal |
2.231100E-04 |
| Tall-VS-Follicular |
9.180400E-01 |
| Tall-VS-Other |
9.987000E-01 |
| Tall-VS-Normal |
7.83080000000824E-05 |
| Follicular-VS-Other |
9.556800E-01 |
| Follicular-VS-Normal |
1.11010000003464E-06 |
| Other-VS-Normal |
2.678500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.36579999987907E-07 |
| Normal-vs-N1 |
6.05230000005896E-07 |
| N0-vs-N1 |
2.870400E-01 |
|
|
